Research & Studies

CA Clinics is a strong advocate of the need for research and studies to form the basis for advancing therapies that may offer viable options for patients struggling to get desired outcomes from more traditional approaches.

Medicinal Cannabis Research Programs Australia

CA Clinics is a strong advocate of the need for research to form the basis for advancing therapies, including medicinal cannabis, that may offer viable options for patients struggling to get desired outcomes from existing therapies.

We have partnered with Applied Cannabis Research in order to be able to provide CA Clinics patients with the opportunity to be a part of research studies. 

CA Clinics is involved in research in several ways: 

  • Conducting its own observational study: the CACOS study
  • By acting as a participating site for external studies in the medicinal cannabis space. Please see current opportunities.

Bod Australia Observational Study of Medicinal Cannabis Therapy

Findings of these studies play an important part in helping develop medicinal cannabis treatments in Australia and better informing healthcare professionals about when and how to use these treatments.

CA Clinics Observational Study - CACOS Study

The CA Clinics Observational Study (CACOS) is open to all patients that are undergoing treatment at CA Clinics.
Within the CACOS study there are sub-studies focused on different indications such as chronic pain, PTSD or anxiety, to name a few, and also focused on different types of medicinal cannabis products from a range of suppliers.

In addition to the overarching study covering a broad range of medicinal cannabis treatments we have specific focus into the following areas:

  • A broad-based pain study using a range of medications for sufferers of chronic pain,
  • A specific Veteran’s community sub-study into the impact on their treatment,
  • Investigation of the impact on pain and associated mental health conditions, especially anxiety, which often presents ‘hand-in-hand’ with pain.
  • A specific focus into Anxiety treatments and the impact of medicinal cannabis.

The CACOS study currently has sub-studies with the following companies:

For interested patients please see the Patient Information and Consent Form ; specifically “Section 2: Research at CA Clinics” which outlines what is involved in research participation in the CACOS study.

Applied Cannabis Research

Applied Cannabis Research (ACR) is a contract research organisation specialising in clinical research studies in the field of medicinal cannabis. ACR is currently facilitating a range of observational studies into various conditions for patients being prescribed medicinal cannabis products.

Working with interested companies, authorities and clinicians, Applied Cannabis Research is staffed with academics, researchers and clinicians working in the field of medicinal cannabis.

The CACOS and CMOS studies are the current flagships for ACR.

Both of these studies are focused on collecting data from patients related to the dose of prescribed cannabis products, adverse events they may be experiencing and other health-related outcome measures that can be used to determine how well patients are responding to medicinal cannabis treatment.

Both studies include patients with all different conditions including, but not limited to, cancer-related pain and symptoms, epilepsy, anxiety, PTSD and a range of chronic pain conditions.

If you are interested in being contacted by ACR about new research opportunities you can express your interest here.